How I treat acute chest syndrome in children with sickle cell disease

Blood

Volumn 117, Issue 20, 2011, Pages 5297-5305

  Miller, Scott T ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; DEXAMETHASONE; HYDROMORPHONE; HYDROXYUREA; IMMUNOGLOBULIN; KETOROLAC; MACROLIDE; METHYLPREDNISOLONE; MORPHINE; NALBUPHINE; NITRIC OXIDE; OPIATE; PETHIDINE; PLACEBO; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; SECRETORY PHOSPHOLIPASE A2; VARESPLADIB;

ACUTE CHEST SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ARTICLE; ASTHMA; ASTHMATIC STATE; BACKACHE; BLOOD TRANSFUSION REACTION; BRAIN HEMORRHAGE; CHILDHOOD DISEASE; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DRUG EFFICACY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FAT EMBOLISM; HUMAN; LUNG EMBOLISM; MYCOPLASMA PNEUMONIAE; NONHUMAN; OXYGEN THERAPY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RECURRENT DISEASE; SICKLE CELL ANEMIA; STREPTOCOCCUS PNEUMONIAE; THORAX PAIN; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

EID: 79956356990     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-261834     Document Type: Article

References (121)

1. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics. 1989;84(3):500-508. (Pubitemid 19216350)
2. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103(11):4023-4027. (Pubitemid 38685339)
3. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med. 1979;139(1):67-69. (Pubitemid 10131851)
4. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342(25):1855-1865. (Pubitemid 30419049)
5. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997;89(5):1787-1792. (Pubitemid 27097475)
6. Shulman ST, Bartlett J, Clyde WA Jr, Ayoub EM. The unusual severity of Mycoplasmal pneumoniae in children with sickle-cell disease. N Engl J Med. 1972;287(4):164-167.
7. Becton DL, Friedman HS, Kurtzberg J, Chaffee S, Falletta JM, Kinney TR. Severe Mycoplasma pneumoniae in three sisters with sickle cell disease. Pediatr Hematol Oncol. 1986;3(3):259-265. (Pubitemid 17018333)
8. Dean D, Neumayr L, Kelly DM, et al. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. J Pediatr Hematol Oncol. 2003;25(1):46-55. (Pubitemid 36070964)
9. Neumayr L, Lennette E, Kelly D, et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003;112 (1 Pt 1):87-95. (Pubitemid 36792934)
10. Fabian TC. Unraveling the fat embolism syndrome. N Engl J Med. 1993;329(13):961-963. (Pubitemid 23275282)
11. Fabian TC, Hoots AV, Stanford DS, Patterson CR, Mangiante EC. Fat embolism syndrome: prospective evaluation in 92 fracture patients. Crit Care Med. 1990;18(1):42-46. (Pubitemid 20039154)
12. Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ. Bone marrow embolism in sickle cell disease: a review. Am J Hematol. 2005;79(1):61-67. (Pubitemid 40604795)
13. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994;83(11):3107-3112. (Pubitemid 24158452)
14. Rao S, Solomon N, Miller S, Dunn E. Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease. J Pediatr. 1985;107(5):685-688. (Pubitemid 16250501)
15. Wade LJ, Stevenson LD. Necrosis of the bone marrow with fat embolism in sickle cell anemia. Am J Pathol. 1941;17(1):47-54 45.
16. Castro O. Systemic fat embolism and pulmonary hypertension in sickle cell disease. Hematol Oncol Clin North Am. 1996;10(6):1289-1303. (Pubitemid 26412251)
17. Nevalainen TJ. Serum phospholipases A2 in inflammatory diseases. Clin Chem. 1993;39(12):2453-2459. (Pubitemid 2007974)
18. Hulman G. Pathogenesis of non-traumatic fat embolism. Lancet. 1988;1(8599):1366-1367.
19. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996;87(6):2573-2578. (Pubitemid 26086904)
20. Styles LA, Aarsman AJ, Vichinsky EP, Kuypers FA. Secretory phospholipase A (2) predicts impending acute chest syndrome in sickle cell disease. Blood. 2000;96(9):3276-3278.
21. Ballas SK, Files B, Luchtman-Jones L, et al. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006;30(2):165-170. (Pubitemid 43977317)
22. Styles LA, Abboud M, Larkin S, Lo M, Kuypers FA. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007;136(2):343-344. (Pubitemid 46020766)
23. Oslund RC, Cermak N, Gelb MH. Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. J Med Chem. 2008;51(15):4708-4714.
24. Miller ST, Hammerschlag MR, Chirgwin K, et al. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease. J Pediatr. 1991;118(1):30-33.
25. Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis. 2007;44(4):568-576. (Pubitemid 46233262)
26. Saikku P, Ruutu P, Leinonen M, Kleemola M, Paladin F, Tupasi TE. Mycoplasma pneumoniae and Chlamydia trachomatis in acute lower respiratory infections in Filipino children. Am J Trop Med Hyg. 1993;49(1):88-92. (Pubitemid 23242761)
27. Podsiadly E, Fracka B, Szmigielska A, Tylewska-Wierzbanowska S. Seroepidemiologic studies of Chlamydia pneumoniae infections in 1-36 months old children with respiratory tract infections and other diseases in Poland. Pol J Microbiol. 2005;54(3):215-219. (Pubitemid 41392049)
28. Matsumoto T, Matsumura K, Anwar KS, et al. Prevalence of Chlamydophila pneumoniae among Bangladeshi children under age 5 years with acute respiratory infections. J Infect Chemother. 2006;12(3):139-144. (Pubitemid 44025016)
29. Grayston JT, Diwan VK, Cooney M, Wang SP. Community-and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med. 1989;149(1):169-173. (Pubitemid 19036833)
30. Barrett-Connor E. Acute pulmonary disease and sickle cell anemia. Am Rev Respir Dis. 1971;104(2):159-165.
31. Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. J Pediatr. 1985;107(6):861-866. (Pubitemid 16197091)
32. Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease. A retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol Oncol. 1986;8(2):105-110. (Pubitemid 16092150)
33. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis; 201 (1):32-41.
34. Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR. Human parvovirus infection in homozygous sickle cell disease. Lancet. 1993;341(8855):1237-1240. (Pubitemid 23146929)
35. Godeau B, Galacteros F, Schaeffer A, et al. Aplastic crisis due to extensive bone marrow necrosis and human parvovirus infection in sickle cell disease. Am J Med. 1991;91(5):557-558.
36. Strouse JJ, Reller ME, Bundy DG, et al. Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease. Blood; 116 (18):3431-3434.
37. Hooker EA, Danzl DF, Brueggmeyer M, Harper E. Respiratory rates in pediatric emergency patients. J Emerg Med. 1992;10(4):407-410.
38. Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough? Ann Emerg Med. 1999;34(1):64-69. (Pubitemid 29295753)
39. Blaisdell CJ, Goodman S, Clark K, Casella JF, Loughlin GM. Pulse oximetry is a poor predictor of hypoxemia in stable children with sickle cell disease. Arch Pediatr Adolesc Med. 2000;154(9):900-903.
40. Rackoff WR, Kunkel N, Silber JH, Asakura T, Ohene-Frempong K. Pulse oximetry and factors associated with hemoglobin oxygen desaturation in children with sickle cell disease. Blood. 1993;81(12):3422-3427. (Pubitemid 23172929)
41. Campbell A, Minniti CP, Nouraie M, et al. Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients. Br J Haematol. 2009;147(3):352-359.
42. Fitzgerald RK, Johnson A. Pulse oximetry in sickle cell anemia. Crit Care Med. 2001;29(9):1803-1806. (Pubitemid 32848385)
43. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294. (Pubitemid 28018756)
44. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84(2):643-649. (Pubitemid 24215969)
45. Morris CR. Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol. 2009;84(4):234-241.
46. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax. 2005;60(3):206-210. (Pubitemid 40380278)
47. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006;108(9):2923-2927.
48. Handelsman E, Voulalas D. Albuterol inhalations in acute chest syndrome. Am J Dis Child. 1991;145(6):603-604.
49. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med. 2005;172(9):1078-1089. (Pubitemid 43066642)
50. Hammerschlag MR. Chlamydia pneumoniae and asthma in children: diagnostic issues. Clin Infect Dis. 2004;39(8):1251-1252, author reply 1252-1253.
51. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995;333(11):699-703.
52. Hsu LL, Batts BK, Rau JL. Positive expiratory pressure device acceptance by hospitalized children with sickle cell disease is comparable to incentive spirometry. Respir Care. 2005;50(5):624-627. (Pubitemid 46190331)
53. Needleman JP, Benjamin LJ, Sykes JA, Aldrich TK. Breathing patterns during vaso-occlusive crisis of sickle cell disease. Chest. 2002;122(1):43-46. (Pubitemid 34754141)
54. Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 1997;53(1):139-188. (Pubitemid 27045700)
55. Kay RM, Directo MP, Leathers M, Myung K, Skaggs DL. Complications of ketorolac use in children undergoing operative fracture care. J Pediatr Orthop. 30 (7):655-658.
56. Grisham JT, Vichinsky EP. Ketorolac versus meperidine in vaso-occlusive crisis: a study of safety and efficacy. Int J Pediatr Hematol Oncol. 1996;3:239-247. (Pubitemid 26364559)
57. Beiter JL Jr., Simon HK, Chambliss CR, Adamkiewicz T, Sullivan K. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. Arch Pediatr Adolesc Med. 2001;155(4):496-500. (Pubitemid 32280671)
58. Buchanan ID, Woodward M, Reed GW. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatr Blood Cancer. 2005;45(5):716-724. (Pubitemid 41279365)
59. Yeh YC, Lin TF, Lin FS, Wang YP, Lin CJ, Sun WZ. Combination of opioid agonist and agonist-antagonist: patient-controlled analgesia requirement and adverse events among differentratio morphine and nalbuphine admixtures for postoperative pain. Br J Anaesth. 2008;101(4):542-548.
60. Emre U, Miller ST, Rao SP, Rao M. Alveolararterial oxygen gradient in acute chest syndrome of sickle cell disease. J Pediatr. 1993;123(2):272-275. (Pubitemid 23221111)
61. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317-1322.
62. Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001;97(11):3628-3632.
63. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood. 1999;94(5):1550-1554. (Pubitemid 29411304)
64. Wang WC, Ware RE, Miller ST, et al. Amulticenter randomised controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia. Lancet, in press.
65. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore). 1988;67(1):66-76. (Pubitemid 18064307)
66. Hankins JS, Ware RE, Rogers ZR, et al. Longterm hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood. 2005;106(7):2269-2275. (Pubitemid 41510795)
67. Miller ST, Wright E, Abboud M, et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001;139(6):785-789. (Pubitemid 34014456)
68. Cunha BA. The clinical diagnosis of Mycoplasma pneumoniae: the diagnostic importance of highly elevated serum cold agglutinins. Eur J Clin Microbiol Infect Dis. 2008;27(10):1017-1019.
69. Wilimas JA, Flynn PM, Harris S, et al. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease. N Engl J Med. 1993;329(7):472-476. (Pubitemid 23222333)
70. Centers for Disease Control and Prevention. Seasonal influenza. Available at: http://www.cdc.gov/flu/professionals/. Accessed April 1, 2011.
71. Zipursky A, Robieux IC, Brown EJ, et al. Oxygen therapy in sickle cell disease. Am J Pediatr Hematol Oncol. 1992;14(3):222-228.
72. Haynes J Jr., Allison RC. Pulmonary edema. Complication in the management of sickle cell pain crisis. Am J Med. 1986;80(5):833-840. (Pubitemid 16033704)
73. Firth PG, Tsuruta Y, Kamath Y, Dzik WH, Ogilvy CS, Peterfreund RA. Transfusion-related acute lung injury or acute chest syndrome of sickle cell disease? A case report. Can J Anaesth. 2003;50(9):895-899. (Pubitemid 38139534)
74. Radel EG, Kochen JA, Finberg L. Hyponatremia in sickle cell disease. A renal salt-losing state. J Pediatr. 1976;88(5):800-805.
75. Itano HA, Keitel HG, Thompson D. Hyposthenuria in sickle cell anemia: a reversible renal defect. J Clin Invest. 1956;35(9):998-1007.
76. Charache S, Moyer MA, Walker WG. Treatment of acute sickle cell crises with a vasopressin analogue. Am J Hematol. 1983;15(4):315-319. (Pubitemid 14206074)
77. Gill G, Leese G. Hyponatraemia: biochemical and clinical perspectives. Postgrad Med J. 1998;74(875):516-523. (Pubitemid 28444704)
78. Mallouh AA, Asha M. Beneficial effect of blood transfusion in children with sickle cell chest syndrome. Am J Dis Child. 1988;142(2):178-182. (Pubitemid 18081260)
79. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr. 1995;127(6):901-904. (Pubitemid 26003282)
80. Sakhalkar VS, Rao SP, Weedon J, Miller ST. Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy. Am J Hematol. 2004;76(1):57-60. (Pubitemid 38579539)
81. Duits AJ, Pieters RC, Saleh AW, et al. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin Immunol Immunopathol. 1996;81(1):96-98. (Pubitemid 26338254)
82. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood. 1999;94(5):1555-1560. (Pubitemid 29411305)
83. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood. 1996;88(6):2311-2320. (Pubitemid 26307936)
84. Liem RI, O'Gorman MR, Brown DL. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome. Am J Hematol. 2004;76(1):19-25. (Pubitemid 38579533)
85. Abboud MR, Taylor EC, Habib D, et al. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000;111(2):482-490. (Pubitemid 32009340)
86. Afenyi-Annan A, Kail M, Combs MR, Orringer EP, Ashley-Koch A, Telen MJ. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion. 2008;48(5):917-924. (Pubitemid 351614902)
87. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood. 1997;89(9):3077-3091.
88. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001;41(9):1086-1092. (Pubitemid 32848083)
89. Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003;111 (6 Pt 1): e661-665.
90. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood. 1993;81(5):1109-1123. (Pubitemid 23067344)
91. Velasquez MP, Mariscalco MM, Goldstein SL, Airewele GE. Erythrocytapheresis in children with sickle cell disease and acute chest syndrome. Pediatr Blood Cancer. 2009;53(6):1060-1063.
92. Alexy T, Pais E, Armstrong JK, Meiselman HJ, Johnson CS, Fisher TC. Rheologic behavior of sickle and normal red blood cell mixtures in sickle plasma: implications for transfusion therapy. Transfusion. 2006;46(6):912-918. (Pubitemid 43800909)
93. Chien S, Kaperonis AA, King RG, et al. Rheology of sickle cells and its role in microcirculatory dynamics. Prog Clin Biol Res. 1987;240:151-165.
94. Schmalzer EA, Lee JO, Brown AK, Usami S, Chien S. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion. Transfusion. 1987;27(3):228-233. (Pubitemid 17087588)
95. Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST. A short course of prednisone in the management of acute chest syndrome of sickle cell disease. J Pediatr Hematol Oncol. 2010;32(3): e91-94.
96. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333(4):206-213.
97. Lanzkowsky P, Shende A, Karayalcin G, Kim YJ, Aballi AJ. Partial exchange transfusion in sickle cell anemia. use in children with serious complications. Am J Dis Child. 1978;132(12):1206-1208. (Pubitemid 9135602)
98. Piomelli S, Seaman C, Ackerman K, Yu E, Blei F. Planning an exchange transfusion in patients with sickle cell syndromes. Am J Pediatr Hematol Oncol. 1990;12(3):268-276. (Pubitemid 20323423)
99. Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood. 1998;92(9):3082-3089. (Pubitemid 28492313)
100. Strouse JJ, Takemoto CM, Keefer JR, Kato GJ, Casella JF. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer. 2008;50(5):1006-1012. (Pubitemid 351500179)
101. Belcher JD, Mahaseth H, Welch TE, et al. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol. 2005;288(6):H2715-H2725. (Pubitemid 40720650)
102. Darbari DS, Castro O, Taylor JGt, et al. Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J Natl Med Assoc. 2008;100(8):948-951.
103. Bederman SS, Bhandari M, McKee MD, Schemitsch EH. Do corticosteroids reduce the risk of fat embolism syndrome in patients with longbone fractures? A meta-analysis. Can J Surg. 2009;52(5):386-393.
104. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954-963. (Pubitemid 46608692)
105. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2007 (3): CD000195.
106. Sobota A, Graham DA, Heeney MM, Neufeld EJ. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol; 85 (1):24-28.
107. Isakoff MS, Lillo JA, Hagstrom JN. A single-institution experience with treatment of severe acute chest syndrome: lack of rebound pain with dexamethasone plus transfusion therapy. J Pediatr Hematol Oncol. 2008;30(4):322-325. (Pubitemid 351507590)
108. Fortenberry JD, Del Toro J, Jefferson LS, Evey L, Haase D. Management of pediatric acute hypoxemic respiratory insufficiency with bilevel positive pressure (BiPAP) nasal mask ventilation. Chest. 1995;108(4):1059-1064.
109. Padman R, Henry M. The use of bilevel positive airway pressure for the treatment of acute chest syndrome of sickle cell disease. Del Med J. 2004;76(5):199-203.
110. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program. 2007:91-96.
111. Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med. 2006;119(10):897.e7-11.
112. Martinez-Ruiz R, Montero-Huerta P, Hromi J, Head CA. Inhaled nitric oxide improves survival rates during hypoxia in a sickle cell (SAD) mouse model. Anesthesiology. 2001;94(6):1113-1118. (Pubitemid 32506141)
113. Head CA, Brugnara C, Martinez-Ruiz R, et al. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest. 1997;100(5):1193-1198. (Pubitemid 27386304)
114. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology. 1997;87(4):988-990. (Pubitemid 27456256)
115. Sullivan KJ, Goodwin SR, Evangelist J, Moore RD, Mehta P. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med. 1999;27(11):2563-2568.
116. Oppert M, Jorres A, Barckow D, Eckardt KU, Frei U, Kaisers U. Inhaled nitric oxide for ARDS due to sickle cell disease. Swiss Med Wkly. 2004;134 (11-12): 165-167. (Pubitemid 38418936)
117. Amigoni A, Corner P, Zanella F, Pettenazzo A. Successful use of inhaled nitric oxide in a child with fat embolism syndrome. J Trauma. 2010;68(3):E80-82.
118. Al Hajeri A, Serjeant GR, Fedorowicz Z. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev. 2008 (1): CD006957.
119. Afshari A, Brok J, Moller AM, Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev (7): CD002787.
120. Marti-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev. 2007 (2): CD006110.
121. Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev. 2010 (1): CD007843.